The polyphenolic compounds depicted in Figure 3 represent a multifaceted approach in combating AD by targeting its core pathological pathways, including oxidative stress, neuroinflammation, Aβ aggregation, and tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.